Literature DB >> 18225538

The effects of reactive species on the tumorigenic phenotype of human head and neck squamous cell carcinoma (HNSCC) cells.

Jennifer E Bradburn1, Ping Pei, Laura A Kresty, James C Lang, Allan J Yates, Adam P McCormick, Susan R Mallery.   

Abstract

Sustained inflammation up-regulates the reactive species (RS) generating enzymes inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). While clinical data show that levels of iNOS and COX-2 are increased in epithelium during the transformation of dysplasia to overt head and neck squamous cell carcinoma (HNSCC), the mechanisms by which their overexpression contributes to HNSCC development have not been completely delineated. This study assessed the effects of RS on parameters associated with the HNSCC tumorigenic phenotype inclusive of activation of NF-kappaB (in situ immunostaining and reporter assay) and production of proinflammatory and proangiogenic proteins (ELISA analyses). Our data, which show both reactive oxygen and nitrogen species activated NF-kappaB, and that all RS donors evaluated increased HNSCC cellular production of vascular endothelial growth factor, IL-8 and epidermal growth factor receptor proteins, imply inflammation associated RS promote HNSCC by their abilities to modulate intracellular signaling and affect gene expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18225538      PMCID: PMC2408378     

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  54 in total

1.  Thiol redox modulation of doxorubicin mediated cytotoxicity in cultured AIDS-related Kaposi's sarcoma cells.

Authors:  S R Mallery; Y M Clark; G M Ness; O M Minshawi; P Pei; C M Hohl
Journal:  J Cell Biochem       Date:  1999-05-01       Impact factor: 4.429

2.  8-Nitroguanine formation in oral leukoplakia, a premalignant lesion.

Authors:  Ning Ma; Toshiro Tagawa; Yusuke Hiraku; Mariko Murata; Xiaohui Ding; Shosuke Kawanishi
Journal:  Nitric Oxide       Date:  2005-11-14       Impact factor: 4.427

3.  Sanguinarine activates polycyclic aromatic hydrocarbon associated metabolic pathways in human oral keratinocytes and tissues.

Authors:  Jeffrey M Karp; Kapila A Rodrigo; Ping Pei; Matthew D Pavlick; Jeffrey D Andersen; Dennis J McTigue; Henry W Fields; Susan R Mallery
Journal:  Toxicol Lett       Date:  2005-04-01       Impact factor: 4.372

Review 4.  Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation.

Authors:  Patrick Viatour; Marie-Paule Merville; Vincent Bours; Alain Chariot
Journal:  Trends Biochem Sci       Date:  2005-01       Impact factor: 13.807

Review 5.  The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis.

Authors:  Daniel J Brat; Anita C Bellail; Erwin G Van Meir
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

6.  Cyclooxygenase-2 (COX-2) is directly involved but not decisive in proliferation of human hepatocellular carcinoma cells.

Authors:  Joong-Won Park; Jung Eun Park; Jung Ahn Lee; Chang-Woo Lee; Chang-Min Kim
Journal:  J Cancer Res Clin Oncol       Date:  2005-12-06       Impact factor: 4.553

Review 7.  Cyclooxygenase-2 in hepatocellular carcinoma.

Authors:  Tong Wu
Journal:  Cancer Treat Rev       Date:  2005-12-07       Impact factor: 12.111

8.  Microvessel density and expression of vascular endothelial growth factor, basic fibroblast growth factor, and platelet-derived endothelial growth factor in oral squamous cell carcinomas.

Authors:  C Li; S Shintani; N Terakado; S K Klosek; T Ishikawa; K Nakashiro; H Hamakawa
Journal:  Int J Oral Maxillofac Surg       Date:  2005-01-26       Impact factor: 2.789

9.  Increased nitric oxide levels and iNOS over-expression in oral squamous cell carcinoma.

Authors:  Stephen T Connelly; Maricris Macabeo-Ong; Nusi Dekker; Richard C K Jordan; Brian L Schmidt
Journal:  Oral Oncol       Date:  2005-03       Impact factor: 5.337

10.  Overexpression of 5-lipoxygenase and cyclooxygenase 2 in hamster and human oral cancer and chemopreventive effects of zileuton and celecoxib.

Authors:  Ning Li; Sandeep Sood; Su Wang; Mingzhu Fang; Peng Wang; Zheng Sun; Chung S Yang; Xiaoxin Chen
Journal:  Clin Cancer Res       Date:  2005-03-01       Impact factor: 12.531

View more
  1 in total

1.  Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3.

Authors:  Rebecca J Leeman-Neill; Sarah E Wheeler; Shivendra V Singh; Sufi M Thomas; Raja R Seethala; Daniel B Neill; Mary C Panahandeh; Eun-Ryeong Hahm; Sonali C Joyce; Malabika Sen; Quan Cai; Maria L Freilino; Changyou Li; Daniel E Johnson; Jennifer R Grandis
Journal:  Carcinogenesis       Date:  2009-09-16       Impact factor: 4.944

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.